Management of acquired resistance to ALK inhibitors: Repeat biopsy to characterize mechanisms of resistance does not significantly impact clinical outcomes

by Naiyarat Prasongsook, Thanyanan Reungwetwattana
Published 2022

Association of histologic subtypes with genetic alteration and pd-l1 expression in pulmonary adenocarcinoma

by Bantita Phruttinarakorn, Thanyanan Reungwetwattana, Pimpin Incharoen
Published 2020

MET exon 14 deletion (METex14): Finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of "40 years of wilderness"...

by Thanyanan Reungwetwattana, Sai Hong Ignatius Ou
Published 2018

Current and emerging therapies in peripheral T-cell lymphoma: Focus on pralatrexate

by Thanyanan Reungwetwattana, Sylvia Jaramillo, Julian R. Molina
Published 2018

มะเร็งปอดชนิดยีนกลายพันธุ์ EGFR

by ธัญนันท์ เรืองเวทย์วัฒนา, Thanyanan Reungwetwattana
Published 2023

Dacomitinib as first-line treatment for EGFR mutation-positive non-small cell lung cancer

by Thanyanan Reungwetwattana, Nitesh Rohatgi, Tony S. Mok, Kumar Prabhash
Published 2022

Chemotherapy for non-small-cell lung carcinoma: From a blanket approach to individual therapy

by Thanyanan Reungwetwattana, Matthew J. Eadens, Julian R. Molina
Published 2018

Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC)

by Thanyanan Reungwetwattana, Saravut J. Weroha, Julian R. Molina
Published 2018

The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the Inevitable

by Thanyanan Reungwetwattana, Ying Liang, Viola Zhu, Sai Hong Ignatius Ou
Published 2018

Lung Cancer in Thailand

by Thanyanan Reungwetwattana, Songporn Oranratnachai, Putipun Puataweepong, Viratch Tangsujaritvijit, Piya Cherntanomwong
Published 2020

Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis

by Anne Julienne Genuino, Usa Chaikledkaew, Due Ong The, Thanyanan Reungwetwattana, Ammarin Thakkinstian
Published 2020

Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines

by Anne Julienne Genuino, Usa Chaikledkaew, Anna Melissa Guerrero, Thanyanan Reungwetwattana, Ammarin Thakkinstian
Published 2020

Economic evaluation of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer: systematic review and quality assessment

by Anne Julienne Genuino, Mac Ardy Junio Gloria, Usa Chaikledkaew, Thanyanan Reungwetwattana, Ammarin Thakkinstian
Published 2020

Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis

by Songporn Oranratnachai, Sasivimol Rattanasiri, Anantaporn Pooprasert, Amarit Tansawet, Thanyanan Reungwetwattana, John Attia, Ammarin Thakkinstian
Published 2022

ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy

by Pimpin Incharoen, Thanyanan Reungwetwattana, Sakditad Saowapa, Kaettipong Kamprerasart, Duangjai Pangpunyakulchai, Lalida Arsa, Artit Jinawath
Published 2017

กระบวนการซ่อมแซมดีเอ็นเอกับการรักษาโรคมะเร็งยุคใหม่

by ดลนิภัทร เดชสุพงศ์, ธัญนันท์ เรืองเวทย์วัฒนา, Donniphat Dejsuphong, Thanyanan Reungwetwattana
Published 2022

Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy

by Chalirmporn Atasilp, Phichai Chansriwong, Ekaphop Sirachainan, Thanyanan Reungwetwattana, Suwannee Sirilerttrakul, Monpat Chamnanphon, Apichaya Puangpetch, Chonlaphat Sukasem
Published 2020

Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients

by Keatdamrong Janpipatkul, Narumol Trachu, Piyakarn Watcharenwong, Wittaya Panvongsa, Wittawin Worakitchanon, Chanatip Metheetrairut, Songporn Oranratnachai, Thanyanan Reungwetwattana, Arthit Chairoungdua
Published 2022

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

by Krittiya Korphaisarn, Pongwut Danchaivijitr, Thanyanan Reungwetwattana, Busayamas Chewaskulyong, Luangyot Thongthieang, Jarin Chindaprasirt, Kunlatida Maneenil, Chirawadee Sathitruangsak, Chanida Vinayanuwattikun
Published 2022

Role of BIM deletion polymorphism and BIM expression as predictive biomarkers to maximize the benefit of EGFR-TKI treatment in EGFR-Positive NSCLC

by Pimpin Incharoen, C. Charonpongsuntorn, Chanchai Sakditad Saowapa, Ekaphop Sirachainan, Thitiya Dejthevaporn, Kaettipong Kampreasart, Narumol Trachu, Dittapol Muntham, Thanyanan Reungwetwattana
Published 2020